The Use of Butyrate Therapy in Pediatric Ulcerative Colitis | MicrobiomeTrials← Back to trialsNCT05218850
The Use of Butyrate Therapy in Pediatric Ulcerative Colitis
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2022-06-29Est. Completion: 2027-06-30
Enrollment target: 10 participants Locations- Children's Hospital Los Angeles, Los Angeles, California, United States
Other microbiome trials you might be interested in
Inflammatory Bowel DiseaseCrohn's DiseaseUlcerative Colitis
Background:
Inflammatory bowel disease (IBD) is a term used to describe disorders that cause long-term inflammation in …
Bethesda, United StatesEst. completion Jun 1, 2036
Inflammatory Bowel Disease
Crohn's Disease (CD) and Ulcerative Colitis (UC), collectively known as inflammatory bowel disease (IBD), are two of the…
Chicago, United StatesEst. completion Sep 1, 2026
Recruiting
Ulcerative colitis (UC) is a chronic inflammatory bowel disease that requires regular monitoring of disease activity. Cu…
Asyut, EgyptEst. completion Jan 31, 2027